AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
MUTATIONS IN OGG1, A GENE INVOLVED IN THE REPAIR OF OXIDATIVE DNA-DAMAGE, ARE FOUND IN HUMAN LUNG AND KIDNEY TUMORS
Authors: CHEVILLARD S RADICELLA JP LEVALOIS C LEBEAU J POUPON MF OUDARD S DUTRILLAUX B BOITEUX S
Citation: S. Chevillard et al., MUTATIONS IN OGG1, A GENE INVOLVED IN THE REPAIR OF OXIDATIVE DNA-DAMAGE, ARE FOUND IN HUMAN LUNG AND KIDNEY TUMORS, Oncogene, 16(23), 1998, pp. 3083-3086
P53, MDR1 AND SPF PROGNOSTIC RELEVANCE IN BREAST-CANCER
Authors: VIELH P POUILLART P KLIJANIENKO J FOURQUET A CHEVILLARD S
Citation: P. Vielh et al., P53, MDR1 AND SPF PROGNOSTIC RELEVANCE IN BREAST-CANCER, Modern pathology, 11(1), 1998, pp. 29-29
P53, MDR1 AND SPF PROGNOSTIC RELEVANCE IN BREAST-CANCER
Authors: VIELH P POUILLART P KLIJANIENKO J FOURQUET A CHEVILLARD S
Citation: P. Vielh et al., P53, MDR1 AND SPF PROGNOSTIC RELEVANCE IN BREAST-CANCER, Laboratory investigation, 78(1), 1998, pp. 152-152
BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF CONCURRENT P53 GENE ALTERATIONS, MDR1 GENE-EXPRESSION, AND S-PHASE FRACTION ANALYSES IN BREAST-CANCER PATIENTS TREATED WITH PRIMARY CHEMOTHERAPY OR RADIOTHERAPY
Authors: CHEVILLARD S LEBEAU J POUILLART P DETOMA C BELDJORD C ASSELAIN B KLIJANIENKO J FOURQUET A MAGDELENAT H VIELH P
Citation: S. Chevillard et al., BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF CONCURRENT P53 GENE ALTERATIONS, MDR1 GENE-EXPRESSION, AND S-PHASE FRACTION ANALYSES IN BREAST-CANCER PATIENTS TREATED WITH PRIMARY CHEMOTHERAPY OR RADIOTHERAPY, Clinical cancer research, 3(12), 1997, pp. 2471-2478
MULTICENTRIC EVALUATION OF THE MDR PHENOTYPE IN LEUKEMIA
Authors: MARIE JP HUET S FAUSSAT AM PERROT JY CHEVILLARD S BARBU V BAYLE C BOUTONNAT J CALVO F CAMPOSGUYOTAT L COLOSETTI P CAZIN JL DECREMOUX P DELVINCOURT C DEMUR C DRENOU B FENNETEAU O FEUILLARD J GARNIERSUILLEROT A GENNE P GORISSE MC GOSSELIN P JOUAULT H LACAVE R LECALVEZ G LEGLISE MC LEONCE S MANFAIT M MAYNADIE M MERLEBERAL H MERLIN JL MOUSSEAU M MORJANI H PICARD F PINGUET F PONCELET P RACADOT E RAPHAEL M RICHARD B ROSSI JF SCHLEGEL N VIELH P ZHOU DC ROBERT J
Citation: Jp. Marie et al., MULTICENTRIC EVALUATION OF THE MDR PHENOTYPE IN LEUKEMIA, Leukemia, 11(7), 1997, pp. 1086-1094
FRENCH MULTICENTRIC EVALUATION OF MDR1 GENE-EXPRESSION BY RT-PCR IN LEUKEMIA AND SOLID TUMORS - STANDARDIZATION OF RT-PCR AND PRELIMINARY COMPARISONS BETWEEN RT-PCR AND IMMUNOHISTOCHEMISTRY IN SOLID TUMORS
Authors: CHEVILLARD S VIELH P VALIDIRE P MARIE JP FAUSSAT AM BARBU V BAYLE C BENARD J BONNAL C BOUTONNAT J CALVO F CHARRIER J CLARY A COLOSETTI P DANELMOORE L DECREMOUX P DELVINCOURT C FINATDUCLOS F GENNE P KATAKI A KOUYOUMDJIAN JC LACAVE R MAUGARD C MERLIN JL MOUSSEAU M PINGUET F QUILLIEN V RAPHAEL M RICHARD B VERRELLE P ROBERT J
Citation: S. Chevillard et al., FRENCH MULTICENTRIC EVALUATION OF MDR1 GENE-EXPRESSION BY RT-PCR IN LEUKEMIA AND SOLID TUMORS - STANDARDIZATION OF RT-PCR AND PRELIMINARY COMPARISONS BETWEEN RT-PCR AND IMMUNOHISTOCHEMISTRY IN SOLID TUMORS, Leukemia, 11(7), 1997, pp. 1095-1106
VALUE OF THE PREOPERATIVE DETECTION OF PROSTATE-SPECIFIC-ANTIGEN-POSITIVE CIRCULATING CELLS BY NESTED RT-PCR IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY
Authors: DECREMOUX P RAVERY V PODGORNIAK MP CHEVILLARD S TOUBLANC M THIOUNN N TATOUD R DELMAS V CALVO T BOCCONGIBOD L
Citation: P. Decremoux et al., VALUE OF THE PREOPERATIVE DETECTION OF PROSTATE-SPECIFIC-ANTIGEN-POSITIVE CIRCULATING CELLS BY NESTED RT-PCR IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY, European urology, 32(1), 1997, pp. 69-74
POSITIVE PROSTATE-SPECIFIC ANTIGEN CIRCULATING CELLS DETECTED BY REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION DOES NOT IMPLY THE PRESENCE OF PROSTATIC MICROMETASTASES
Authors: THIOUNN N SAPORTA F FLAM TA PAGES F ZERBIB M VIEILLEFOND A MARTIN E DEBRE B CHEVILLARD S
Citation: N. Thiounn et al., POSITIVE PROSTATE-SPECIFIC ANTIGEN CIRCULATING CELLS DETECTED BY REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION DOES NOT IMPLY THE PRESENCE OF PROSTATIC MICROMETASTASES, Urology, 50(2), 1997, pp. 245-250
MEASURING MULTIDRUG-RESISTANCE EXPRESSION IN HUMAN MALIGNANCIES - ELABORATION OF CONSENSUS RECOMMENDATIONS
Authors: MARIE JP LEGRAND O PERROT JY CHEVILLARD S HUET S ROBERT J
Citation: Jp. Marie et al., MEASURING MULTIDRUG-RESISTANCE EXPRESSION IN HUMAN MALIGNANCIES - ELABORATION OF CONSENSUS RECOMMENDATIONS, Seminars in hematology, 34(4), 1997, pp. 63-71
ELEVATED LEVELS OF BASIC FIBROBLAST GROWTH-FACTOR IN MEGAKARYOCYTES AND PLATELETS FROM PATIENTS WITH IDIOPATHIC MYELOFIBROSIS
Authors: MARTYRE MC LEBOUSSEKERDILES MC ROMQUIN N CHEVILLARD S PRALORAN V DEMORY JL DUPRIEZ B
Citation: Mc. Martyre et al., ELEVATED LEVELS OF BASIC FIBROBLAST GROWTH-FACTOR IN MEGAKARYOCYTES AND PLATELETS FROM PATIENTS WITH IDIOPATHIC MYELOFIBROSIS, British Journal of Haematology, 97(2), 1997, pp. 441-448
DIFFERENT P53 MUTATIONS PRODUCE DISTINCT EFFECTS ON THE ABILITY OF COLON-CARCINOMA CELLS TO BECOME BLOCKED AT THE G1 S BOUNDARY AFTER IRRADIATION/
Authors: POCARD M CHEVILLARD S VILLAUDY J POUPON MF DUTRILLAUX B REMVIKOS Y
Citation: M. Pocard et al., DIFFERENT P53 MUTATIONS PRODUCE DISTINCT EFFECTS ON THE ABILITY OF COLON-CARCINOMA CELLS TO BECOME BLOCKED AT THE G1 S BOUNDARY AFTER IRRADIATION/, Oncogene, 12(4), 1996, pp. 875-882
REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION (RT-PCR) ASSAYS OF ESTROGEN AND PROGESTERONE RECEPTORS IN BREAST-CANCER
Authors: CHEVILLARD S MULLER A LEVALOIS C LAINEBIDRON C VIELH P MAGDELENAT H
Citation: S. Chevillard et al., REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION (RT-PCR) ASSAYS OF ESTROGEN AND PROGESTERONE RECEPTORS IN BREAST-CANCER, Breast cancer research and treatment, 41(1), 1996, pp. 81-89
LONG-TERM PROGNOSTIC VALUE OF GROWTH FRACTION DETERMINATION BY KI-67 IMMUNOSTAINING IN PRIMARY OPERABLE BREAST-CANCER
Authors: PIERGA JY LEROYER A VIEHL P MOSSERI V CHEVILLARD S MAGDELENAT H
Citation: Jy. Pierga et al., LONG-TERM PROGNOSTIC VALUE OF GROWTH FRACTION DETERMINATION BY KI-67 IMMUNOSTAINING IN PRIMARY OPERABLE BREAST-CANCER, Breast cancer research and treatment, 37(1), 1996, pp. 57-64
TC-99MSESTAMIBI UPTAKE IN HUMAN CANCER CELL-LINES RESISTANT TO CHEMOTHERAPY MEDIATED BY MULTIDRUG-RESISTANCE ASSOCLATED PROTEIN(MRP)
Authors: MORETTI JL CORDOBES MD DEBECO V BOISSIER B KOUYOUMDJI JC CHEVILLARD S STARZEC A
Citation: Jl. Moretti et al., TC-99MSESTAMIBI UPTAKE IN HUMAN CANCER CELL-LINES RESISTANT TO CHEMOTHERAPY MEDIATED BY MULTIDRUG-RESISTANCE ASSOCLATED PROTEIN(MRP), The Journal of nuclear medicine, 37(5), 1996, pp. 1051-1051
MDR-1 EXPRESSION AND P53 MUTATIONS IN BREAST-CANCER
Authors: VIELH P LEBEAU J POUILLART P CHEVILLARD S
Citation: P. Vielh et al., MDR-1 EXPRESSION AND P53 MUTATIONS IN BREAST-CANCER, Laboratory investigation, 74(1), 1996, pp. 133-133
SEQUENTIAL ASSESSMENT OF MULTIDRUG-RESISTANCE PHENOTYPE AND MEASUREMENT OF S-PHASE FRACTION AS PREDICTIVE MARKERS OF BREAST-CANCER RESPONSETO NEOADJUVANT CHEMOTHERAPY
Authors: CHEVILLARD S POUILLART P BELDJORD G ASSELAIN B BEUZEBOC P MAGDELENAT H VIELH P
Citation: S. Chevillard et al., SEQUENTIAL ASSESSMENT OF MULTIDRUG-RESISTANCE PHENOTYPE AND MEASUREMENT OF S-PHASE FRACTION AS PREDICTIVE MARKERS OF BREAST-CANCER RESPONSETO NEOADJUVANT CHEMOTHERAPY, Cancer, 77(2), 1996, pp. 292-300
MDR1 GENE-EXPRESSION IN SOLID TUMORS - PR ELIMINARY-RESULTS OF A MULTICENTRIC EVALUATION
Authors: CHEVILLARD S VIELH P VALLIDIRE P ROBERT J MARIE JP
Citation: S. Chevillard et al., MDR1 GENE-EXPRESSION IN SOLID TUMORS - PR ELIMINARY-RESULTS OF A MULTICENTRIC EVALUATION, Bulletin du cancer, 83(8), 1996, pp. 626-633
INDUCTIBILITY OF MDR1 GENE-EXPRESSION, S- PHASE AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY
Authors: MAGDELENAT H CHEVILLARD S BEUZEBOC P PIERGA JY VIELH P POUILLART P
Citation: H. Magdelenat et al., INDUCTIBILITY OF MDR1 GENE-EXPRESSION, S- PHASE AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY, Bulletin du cancer, 83(12), 1996, pp. 1037-1037
DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA, BASIC FIBROBLAST GROWTH-FACTOR, AND THEIR RECEPTORS IN CD34(+) HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA
Authors: LEBOUSSEKERDILES MC CHEVILLARD S CHARPENTIER A ROMQUIN N CLAY D SMADJAJOFFE F PRALORAN V DUPRIEZ B DEMORY JL JASMIN C MARTYRE MC
Citation: Mc. Leboussekerdiles et al., DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA, BASIC FIBROBLAST GROWTH-FACTOR, AND THEIR RECEPTORS IN CD34(+) HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA, Blood, 88(12), 1996, pp. 4534-4546
THE FRENCH MULTICENTRIC EVALUATION OF MDR PHENOTYPE IN LEUKEMIA - CONCLUSIONS AND GUIDELINES
Authors: MARIE JP PERROT JY CHEVILLARD S HUET S FAUSSAT AM ROBERT J
Citation: Jp. Marie et al., THE FRENCH MULTICENTRIC EVALUATION OF MDR PHENOTYPE IN LEUKEMIA - CONCLUSIONS AND GUIDELINES, Blood, 88(10), 1996, pp. 2643-2643
CELLULAR PHARMACOLOGY OF AZATOXINS (TOPOISOMERASE-II AND TUBULIN INHIBITORS) IN P-GLYCOPROTEIN-POSITIVE AND P-GLYCOPROTEIN-NEGATIVE CELL-LINES
Authors: EYMIN B SOLARY E CHEVILLARD S DUBREZ L GOLDWASSER F DUCHAMP O GENNE P LETEURTRE F POMMIER Y
Citation: B. Eymin et al., CELLULAR PHARMACOLOGY OF AZATOXINS (TOPOISOMERASE-II AND TUBULIN INHIBITORS) IN P-GLYCOPROTEIN-POSITIVE AND P-GLYCOPROTEIN-NEGATIVE CELL-LINES, International journal of cancer, 63(2), 1995, pp. 268-275
DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA, BASIC FIBROBLAST GROWTH-FACTOR AND THEIR RECEPTORS IN CD34 HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA
Authors: LEBOUSSEKERDILES MC CHARPENTIER A CHEVILLARD S ROMQUIN N CLAY D SMADJAJOFFE F PRALORAN V DUPRIEZ B DEMORY JL JASMIN C MARTYRE MC
Citation: Mc. Leboussekerdiles et al., DIFFERENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA, BASIC FIBROBLAST GROWTH-FACTOR AND THEIR RECEPTORS IN CD34 HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELOFIBROSIS AND MYELOID METAPLASIA, Blood, 86(10), 1995, pp. 176-176
A RAPIDLY PROGRESSING LEIOMYOSARCOMA EXPRESSING DRUG-RESISTANCE MARKERS FAILED TO RESPOND TO CYCLOSPORINE A-ASSOCIATED CHEMOTHERAPY
Authors: OUDARD S CHEVILLARD S LOKIEC F DORVAL T POUPON MF POUILLART P
Citation: S. Oudard et al., A RAPIDLY PROGRESSING LEIOMYOSARCOMA EXPRESSING DRUG-RESISTANCE MARKERS FAILED TO RESPOND TO CYCLOSPORINE A-ASSOCIATED CHEMOTHERAPY, European journal of cancer, 30A(10), 1994, pp. 1594-1595
A RAPIDLY PROGRESSING LEIOMYOSARCOMA EXPRESSING DRUG-RESISTANCE MARKERS FAILED TO RESPOND TO CYCLOSPORINE A-ASSOCIATED CHEMOTHERAPY
Authors: OUDARD S CHEVILLARD S LOKIEC F DORVAL T POUPON MF POUILLART P
Citation: S. Oudard et al., A RAPIDLY PROGRESSING LEIOMYOSARCOMA EXPRESSING DRUG-RESISTANCE MARKERS FAILED TO RESPOND TO CYCLOSPORINE A-ASSOCIATED CHEMOTHERAPY, European journal of cancer, 30A(10), 1994, pp. 1594-1595
MDR1 GENE-TRANSCRIPTION IN BREAST-CANCER CELLS
Authors: CHEVILLARD S VIELH P POUILLART P
Citation: S. Chevillard et al., MDR1 GENE-TRANSCRIPTION IN BREAST-CANCER CELLS, Pathologie et biologie, 42(10), 1994, pp. 922-922
Risultati: 1-25 | 26-30